FindTrial
Sign In

Primary clinical study of prevention of acute kidney injury induced by X-ray contrast medium with N-acetylcysteine

clinical study of prevention of acute kidney injury induced by X-ray contrast medium with N-acetylcysteine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008795
Enrollment
Unknown
Registered
2016-07-07
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Intervention group:with N-acetylcysteine
Control:No treatment

Sponsors

Peking Universiy Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years of age, normal serum creatinine level, and need to receive radiation therapy in patients with malignant tumor

Exclusion criteria

Exclusion criteria: Patients less than 18 years of age, renal function impairment, use of contrast agent and angiography in the past four days.

Design outcomes

Primary

MeasureTime frame
creatinine;—

Countries

China

Contacts

Public ContactChen Renxiong

Peking Universiy Cancer Hospital

chenrenxiong86@163.com+86 13552495399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026